Research programme: oncolytic viruses - TransgeneAlternative Names: anti-PD-1 immune checkpoint inhibitor - Transgene; J43-armed-Western Reserve oncolytic vaccinia virus; TG 6002; VV-TK-RR-FCU1
Latest Information Update: 28 Nov 2016
At a glance
- Originator Transgene
- Class Immunotherapies; Oncolytic viruses
- Mechanism of Action Checkpoint kinase inhibitors; Immunomodulators; Prodrug activators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Solid tumours